OAM
XLRN

Oxford Asset Management’s Acceleron Pharma XLRN Stock Holding History

Oxford Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,669
Closed -$698K – 2210
2019
Q3 		$698K Sell
17,669
-17,959
-50% -$779K 0.02% 1120
2019
Q2 		$1.46M Buy
+35,628
New +$1.48M 0.03% 794
2016
Q4 		– Sell
-92,215
Closed -$3.34M – 909
2016
Q3 		$3.34M Buy
92,215
+5,954
+7% +$197K 0.1% 256
2016
Q2 		$2.93M Buy
+86,261
New +$2.8M 0.1% 280

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Oxford Asset Management's XLRN Position: Q4 2019 in Review

Oxford Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2019, closing a stake of 17,669 shares — an estimated $698K sold.

Oxford Asset Management first reported a position in XLRN in Q2 2016 and held it in 4 quarters. The position peaked at $3.34M in Q3 2016. 183 funds tracked by Wall St. Rank hold XLRN as of Q4 2019.

  • Oxford Asset Management reported no remaining Acceleron Pharma position as of Q4 2019 after selling out during the quarter.
  • Oxford Asset Management sold 17,669 Acceleron Pharma shares in Q4 2019, an estimated $698K.
  • Oxford Asset Management first reported a position in Acceleron Pharma in Q2 2016 and held it in 4 quarters.
  • Oxford Asset Management's Acceleron Pharma position peaked at $3.34M in Q3 2016.
  • 183 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.